Clinical Lung Cancer

1

nab-Paclitaxel for the Treatment of Advanced Squamous Non–Small-Cell Lung Cancer: A Comprehensive Update

Simon, George R.

Journal:

Year:

2014

Language:

english

File:

PDF, 175 KB

english, 2014

2

Emerging Science and Therapies in Non-small-Cell Lung Cancer: Targeting the MET Pathway

Kris, Mark G., Arenberg, Douglas A., Herbst, Roy S., Riely, Gregory J.

Journal:

Clinical Lung Cancer

Year:

2014

Language:

english

File:

PDF, 75 KB

english, 2014

3

Occult Nodal Disease in Patients With Non–Small-Cell Lung Cancer Who are Suitable for Stereotactic Ablative Body Radiation

Robson, Jonathan M., Vaidyanathan, Sriram, Cheyne, Leanne, Snee, Michael, Franks, Kevin, Callister, Matthew E.J.

Journal:

Clinical Lung Cancer

Year:

2014

Language:

english

File:

PDF, 238 KB

english, 2014

4

Prognostic Molecular Assay Might Improve Identification of Patients At Risk for Recurrence in Early-Stage Non–Small-Cell Lung Cancer

Woodard, Gavitt A., Gubens, Matthew A., Jahan, Thierry M., Jones, Kirk D., Kukreja, Jasleen, Theodore, Pierre R., Cardozo, Shayne, Jew, Gregory, Clary-Macy, Carolyn, Jablons, David M., Mann, Michael J

Journal:

Clinical Lung Cancer

Year:

2014

Language:

english

File:

PDF, 186 KB

english, 2014

5

Prognostic Significance of Genotype and Number of Metastatic Sites in Advanced Non–Small-Cell Lung Cancer

He, Yan-yan, Zhang, Xu-chao, Yang, Jin-ji, Niu, Fei-yu, Zeng, Zhu, Yan, Hong-hong, Xu, Chong-rui, Guan, Ji-lin, Zhong, Wen-zhao, Yang, Lu-lu, Guo, Long-hua, Wu, Yi-long

Journal:

Clinical Lung Cancer

Year:

2014

Language:

english

File:

PDF, 499 KB

english, 2014

6

Strategies to Prevent Brain Metastasis in High-Risk Non–Small-Cell Lung Cancer: Lessons Learned From a Randomized Study of Maintenance Temozolomide Versus Observation

Boggs, D. Hunter, Robins, H. Ian, Langer, Corey J., Traynor, Anne M., Berkowitz, Maurice J., Mehta, Minesh P.

Journal:

Clinical Lung Cancer

Year:

2014

Language:

english

File:

PDF, 708 KB

english, 2014

7

Correlation Between TS, MTHFR, and ERCC1 Gene Polymorphisms and the Efficacy of Platinum in Combination With Pemetrexed First-Line Chemotherapy in Mesothelioma Patients

Powrózek, Tomasz, Kowalski, Dariusz M., Krawczyk, Paweł, Ramlau, Rodryg, Kucharczyk, Tomasz, Kalinka-Warzocha, Ewa, Knetki-Wróblewska, Magdalena, Winiarczyk, Kinga, Dyszkiewicz, Wojciech, Krzakowski,

Journal:

Clinical Lung Cancer

Year:

2014

Language:

english

File:

PDF, 475 KB

english, 2014

8

Diagnosis and Predictive Molecular Analysis of Non–Small-Cell Lung Cancer in the Africa-Middle East Region: Challenges and Strategies for Improvement

Slavik, Tomas, Asselah, Fatima, Fakhruddin, Najla, El Khodary, Ahmed, Torjman, Fairouz, Anis, Elia, Quinn, Martin, Khankan, Azzam, Kerr, Keith M.

Journal:

Clinical Lung Cancer

Year:

2014

Language:

english

File:

PDF, 308 KB

english, 2014

9

Activity of the EGFR-HER2 Dual Inhibitor Afatinib in EGFR-Mutant Lung Cancer Patients With Acquired Resistance to Reversible EGFR Tyrosine Kinase Inhibitors

Landi, Lorenza, Tiseo, Marcello, Chiari, Rita, Ricciardi, Serena, Rossi, Elisa, Galetta, Domenico, Novello, Silvia, Milella, Michele, D'Incecco, Armida, Minuti, Gabriele, Tibaldi, Carmelo, Salvini, Je

Journal:

Clinical Lung Cancer

Year:

2014

Language:

english

File:

PDF, 856 KB

english, 2014

10

Phase II Study of the GI-4000 KRAS Vaccine After Curative Therapy in Patients With Stage I-III Lung Adenocarcinoma Harboring a KRAS G12C, G12D, or G12V Mutation

Chaft, Jamie E., Litvak, Anya, Arcila, Maria E., Patel, Payal, D'Angelo, Sandra P., Krug, Lee M., Rusch, Valerie, Mattson, Alicia, Coeshott, Claire, Park, Bernard, Apelian, David M., Kris, Mark G., Az

Journal:

Clinical Lung Cancer

Year:

2014

Language:

english

File:

PDF, 611 KB

english, 2014

11

Dramatic Response to Crizotinib in ROS1 Fluorescent In Situ Hybridization- and Immunohistochemistry-Positive Lung Adenocarcinoma: A Case Series

Chiari, Rita, Buttitta, Fiamma, Iacono, Daniela, Bennati, Chiara, Metro, Giulio, Di Lorito, Alessia, Iezzi, Manuela, Tiseo, Marcello, Mazzoni, Francesca, Cappuzzo, Federico, Marchetti, Antonio, Crinò,

Journal:

Clinical Lung Cancer

Year:

2014

Language:

english

File:

PDF, 1.30 MB

english, 2014

12

Association Between Baseline Pulmonary Status and Interstitial Lung Disease in Patients With Non–Small-Cell Lung Cancer Treated With Erlotinib—A Cohort Study

Johkoh, Takeshi, Sakai, Fumikazu, Kusumoto, Masahiko, Arakawa, Hiroaki, Harada, Ryosuke, Ueda, Masamichi, Kudoh, Shoji, Fukuoka, Masahiro

Journal:

Clinical Lung Cancer

Year:

2014

Language:

english

File:

PDF, 180 KB

english, 2014

13

Long-Term and Low-Grade Safety Results of a Phase III Study (PARAMOUNT): Maintenance Pemetrexed Plus Best Supportive Care Versus Placebo Plus Best Supportive Care Immediately After Induction Treatment With Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non–Small-Cell Lung Cancer

Pujol, Jean-Louis, Paz-Ares, Luis, de Marinis, Filippo, Dediu, Mircea, Thomas, Michael, Bidoli, Paolo, Corral, Jesus, San Antonio, Belen, Chouaki, Nadia, John, William, Zimmermann, Annamaria, Visseren

Journal:

Clinical Lung Cancer

Year:

2014

Language:

english

File:

PDF, 785 KB

english, 2014

14

Editorial Board

Journal:

Clinical Lung Cancer

Year:

2014

Language:

english

File:

PDF, 103 KB

english, 2014

15

Volume 15; Issue 6

nab-Paclitaxel for the Treatment of Advanced Squamous Non–Small-Cell Lung Cancer: A Comprehensive Update

Emerging Science and Therapies in Non-small-Cell Lung Cancer: Targeting the MET Pathway

Occult Nodal Disease in Patients With Non–Small-Cell Lung Cancer Who are Suitable for Stereotactic Ablative Body Radiation

Prognostic Molecular Assay Might Improve Identification of Patients At Risk for Recurrence in Early-Stage Non–Small-Cell Lung Cancer

Prognostic Significance of Genotype and Number of Metastatic Sites in Advanced Non–Small-Cell Lung Cancer

Strategies to Prevent Brain Metastasis in High-Risk Non–Small-Cell Lung Cancer: Lessons Learned From a Randomized Study of Maintenance Temozolomide Versus Observation

Correlation Between TS, MTHFR, and ERCC1 Gene Polymorphisms and the Efficacy of Platinum in Combination With Pemetrexed First-Line Chemotherapy in Mesothelioma Patients

Diagnosis and Predictive Molecular Analysis of Non–Small-Cell Lung Cancer in the Africa-Middle East Region: Challenges and Strategies for Improvement

Activity of the EGFR-HER2 Dual Inhibitor Afatinib in EGFR-Mutant Lung Cancer Patients With Acquired Resistance to Reversible EGFR Tyrosine Kinase Inhibitors

Phase II Study of the GI-4000 KRAS Vaccine After Curative Therapy in Patients With Stage I-III Lung Adenocarcinoma Harboring a KRAS G12C, G12D, or G12V Mutation

Dramatic Response to Crizotinib in ROS1 Fluorescent In Situ Hybridization- and Immunohistochemistry-Positive Lung Adenocarcinoma: A Case Series

Association Between Baseline Pulmonary Status and Interstitial Lung Disease in Patients With Non–Small-Cell Lung Cancer Treated With Erlotinib—A Cohort Study

Long-Term and Low-Grade Safety Results of a Phase III Study (PARAMOUNT): Maintenance Pemetrexed Plus Best Supportive Care Versus Placebo Plus Best Supportive Care Immediately After Induction Treatment With Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non–Small-Cell Lung Cancer

Editorial Board

Table of Contents